Association of inflammatory biomarkers with depressive symptoms and cognitive decline in a community-dwelling healthy older sample: A 3-year follow-up study

Journal of Affective Disorders

Volumn 173, Issue , 2015, Pages 9-14

  Matsushima, Jun ^a   Kawashima, Toshiro ^a   Nabeta, Hiromi ^a   Imamura, Yoshiomi ^a,b   Watanabe, Itaru ^a,c   Mizoguchi, Yoshito ^a   Kojima, Naoki ^d   Yamada, Shigeto ^e   Monji, Akira ^a  

^a SAGA UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c Ureshino Onsen Hospital   (Japan)

^d Kojima Hospital   (Japan)

^e St Lucia's Hospital   (Japan)

Author keywords

Cognitive decline; Community dwelling healthy older people; Depression; Inflammatory biomarkers; Prospective study

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; SOLUBLE INTERLEUKIN 2 RECEPTOR; SOLUBLE INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID;

AGE; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL FEATURE; CLOCK DRAWING TEST; COGNITION; COGNITIVE DEFECT; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; FRONTAL ASSESSMENT BATTERY; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PATIENT ASSESSMENT; PROTEIN BLOOD LEVEL; SENESCENCE; SEX RATIO; AGING; BLOOD; COMPLICATION; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 84911449634     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2014.10.030     Document Type: Article

References (44)

1. Asevedo, E., Rizzo, L.B., Gadelha, A., Mansur, R.B., Ota, V.K., Berberian, A.A., Scarpato, B.S., Teixeira, A.L., Bressan, R.A., Brietzke, E., 2014. Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia. Physiol. Behav. 129, 194-198.
2. Autry, A.E., Monteggia, L.M., 2012. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64, 238-258.
3. Bai, Y.M., Chiou, W.F., Su, T.P., Li, C.T., Chen, M.H., 2014. Pro-in.ammatory cytokine associated with somatic and pain symptoms in depression. J. Affect. Disord. 155, 28-34.
4. Baune, B.T., Smith, E., Reppermund, S., Air, T., Samaras, K., Lux, O., Brodaty, H., Sachdev, P., Trollor, J.N., 2012. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 37, 1521-1530.
5. Beck, A.T., Steer, R.A., 1984. Internal consistencies of the original and revised Beck Depression Inventory. J. Clin. Psychol. 40, 1365-1367.
6. Beck, A.T., Steer, R.A., Brown, G.K., 1996. Manual for the Beck Depression Inventory-II. The Psychological Corporation, San Antonio, TX.
7. Beck Jr., R.D., Wasserfall, C., Ha, G.K., Cushman, J.D., Huang, Z., Atkinson, M.A., Petitto, J.M., 2005. Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res. 1041, 223-230.
8. Beekman, A.T., Copeland, J.R., Prince, M.J., 1999. Review of community prevalence of depression in later life. Br. J. Psychiatry 174, 307-311.
9. Capuron, L., Ravaud, A., Dantzer, R., 2001. Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom. Med. 63, 376-386.
10. Caraci, F., Copani, A., Nicoletti, F., Drago, F., 2010. Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur. J. Pharmacol. 626, 64-71.
11. da Silva, J., Gonc¸alves-Pereira, M., Xavier, M., Mukaetova-Ladinska, E.B., 2013. Affective disorders and risk of developing dementia: systematic review. Br. J. Psychiatry 202, 177-186.
12. Dik, M.G., Jonker, C., Hack, C.E., Smit, J.H., Comijs, H.C., Eilelenboom, P., 2005. Serum in.ammatory proteins and cognitive decline in older persons. Neurology 64, 1371-1377.
13. Dlugaj, M., Gerwig, M., Wege, Natalia, Siegrist, J., Mann, K., Bröcker-Preuß, M., Dragano, N., Moebus, S., Jöckel, K.H., Bokhof, B., Möhlenkamp, S., Erbel, R., Weimar, C., 2012. Elevated levels of high-sensitivity C-reactive protein are associated with mild cognitive impairment and its subtypes: results of a population-based case-control study. J. Alzheimers Dis. 28, 503-514.
14. Dozois, D.J.A., Dobson, K.S., Ahnberg, J.L., 1998. A psychometric evaluation of the Beck Depression Inventory-II. Psychol. Assess. 10, 83-89.
15. Dubois, B., Slachevsky, A., Litvan, I., Pillon, B., 2000. The FAB: a frontal assessment battery at bedside. Neurology 55, 1621-1626.
16. Eller, T., Aluoja, A., Maron, E., Vasar, V., 2009. Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia. Medicina 45, 971-977.
17. Euteneuer, F., Schwarz, M.J., Dannehl, K., Hartung, A., Westermann, S., Rief, W., 2012. Increased soluble interleukin-2 receptor levels are related to somatic but not to cognitive-affective features in major depression. Brain Behav. Immun. 26, 1244-1248.
18. Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
19. Hänsel, A., Hong, S., Cámara, R.J., von Känel, R., 2010. Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci. Biobehav. Rev. 35, 115-121.
20. Karrenbauer, B.D., Müller, C.P., Ho, Y.J., Spanagel, R., Huston, J.P., Schwarting, R.K., Pawlak, C.R., 2011. Time-dependent in-vivo effects of interleukin-2 on neurotransmitters in various cortices: relationships with depressive-related and anxiety-like behaviour. J. Neuroimmunol. 237, 23-32.
21. Krogh, J., Benros, M.E., Jørgensen, M.B., Vesterager, L., Elfving, B., Nordentoft, M., 2014. The association between depressive symptoms, cognitive function, and inflammation in major depression. Brain Behav. Immun. 35, 70-76.
22. Laurin, D., Curb, J.D., Masaki, K.H., White, L.R., Launer, L.J., 2009. Midlife C-reactive protein and risk of cognitive decline: a 31-year follow-up. Neurobiol. Aging 30, 1724-1727.
23. Li, G.Y., Watanabe, I., Kunitake, Y., Sugataka, K., Muraoka, T., Kojima, N., Kawashima, T., Yamada, S., 2008. Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population. Psychiatry Clin. Neurosci. 62, 562-567.
24. Liu, Y., Ho, R.C., Mak, A., 2012. Interleukin(IL)-6, tumour necrosis factor alpha(TNF-alpha) and soluble interleukin -2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J. Affect. Disord. 139, 230-239.
25. McAfoose, J., Baune, B.T., 2009. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 33, 355-366.
26. McDowell, I., Newell, C., 2006. Measuring Health: A Guide to Rating Scales and Questionnaires, third ed. Oxford University Press Inc., New York, pp. 407-411.
27. McGeer, P.L., McGeer, E.G., 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 21, 195-218.
28. Miller, B.J., Buckley, P., Seabolt, W., Mellor, A., Kirkpatrick, B., 2011. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70, 663-671.
29. Miller, A.H., Maletic, V., Raison, C.L., 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65, 732-741.
30. Nabeta, H., Mizoguchi, Y., Matsushima, J., Imamura, Y., Watanabe, I., Tateishi, T., Kojima, N., Kawashima, T., Yamada, S., Monji, A., 2014. Association of salivary cortisol levels and later depressive state in elderly people living in a rural community: a three-year follow-up study. J. Affect. Disord. 158, 85-89.
31. Ownby, R.L., Crocco, E., Acevedo, A., John, V., Loewenstein, D., 2006. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch. Gen. Psychiatry 63, 530-538.
32. Pasco, J.A., Nicholson, G.C., Williams, L.J., Jacka, F.N., Henry, M.J., Kotowicz, M.A., Schneider, H.G., Leonard, B.E., Berk, M., 2010. Association of high-sensitivity C-reactive protein with de novo major depression. Br. J. Psychiatry 197, 372-377.
33. Pinto, E., Peters, R., 2009. Literature review of the Clock Drawing Test as a tool for cognitive screening. Dement. Geriatr. Cogn. Disord. 27, 201-213.
34. Rouleau, I., Salmon, D.P., Butters, N., Kennedy, C., McGuire, K., 1992. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn. 18, 70-87.
35. Sartori, A.C., Vance, D.E., Slater, L.Z., Crowe, M., 2012. The impact of inflammation on cognitive function in older adults: implications for healthcare practice and research. J. Neurosci. Nurs. 44, 206-217.
36. Satizabal, C.L., Zhu, Y.C., Mazoyer, B., Dufouil, C., Tzourio, C., 2012. Circulating IL-6 and CRP are associated with MRI .ndings in the elderly: the 3C-Dijon Study. Neurology 78, 720-727.
37. Shulman, K.I., Shedletsky, R., Silver, I.L., 1986. The challenge of time: clock-drawing and cognitive function in the elderly. Int. J. Geriatr. Psychiatry 1, 135-140.
38. Stewart, J.C., Rand, K.L., Muldoon, M.F., Kamarck, T.W., 2009. A prospective evaluation of the directionality of the depression-in.ammation relationship. Brain Behav. Immun. 23, 936-944.
39. Valkanova, V., Ebmeier, K.P., Allan, C.L., 2013. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 150, 736-744.
40. Watanabe, I., Li, G.Y., Imamura, Y., Nabeta, H., Kunitake, Y., Ishii, H., Haraguchi, M., Kojima, N., Yamada, S., 2012a. Association of saliva 3-methoxy-4-hydroxyphenylglycol levels and a later depressive state in older subjects living in a rural community. Int. J. Geriatr. Psychiatry 27, 321-326.
41. Watanabe, I., Li, G.Y., Imamura, Y., Nabeta, H., Kunitake, Y., Ishii, H., Haraguchi, M., Furukawa, Y., Tateishi, H., Kojima, N., Nizoguchi, Y., Yamada, S., 2012b. Baseline saliva level of 3-methoxy-4-hydroxyphenylglycole (MHPG) associates with a consequent cognitive decline in non-demented elderly subjects: three-years follow-up study. Psychiatry Res. 195, 125-128.
42. Weinstein, G., Beiser, A.S., Choi, S.H., Preis, S.R., Chen, T.C., Vorgas, D., Au, R., Pikula, A., Wolf, P.A., DeStefano, A.L., Vasan, R.S., Seshadri, S., 2014. Serum brain-derived neurotrophic factor and the risk of dementia: the Framingham Heart Study. JAMA Neurol. 71, 55-61.
43. Wium-Andersen, M.K., Ørsted, D.D., Nielsen, S.F., Nordestgaard, B.G., 2013. Elevated C-reactive protein levels, psychological distress, and depression in 73131 individuals. JAMA Psychiatry 70, 176-184.
44. Woodford, H.J., George, J., 2007. Cognitive assessment in the elderly: a review of clinical methods. Q. J. Med. 100, 469-484.